GlycoNet Investigator and Professor at the University of Toronto, Molly Shoichet has been elected as a Fellow of the Royal Society, the U.K.’s national academy of sciences.
Drs. Alexey V. Pshezhetsky and Christopher Cairo awarded half a million dollars to advance research on inhibitors to treat cardiovascular and autoimmune diseases.
Leveraging her scientific knowledge and entrepreneurial mindset, Dr. Karla Williams is developing a blood test that could allow for early diagnosis of aggressive breast cancer.
GlycoNet awards $1.45 million to eight projects aimed at improving the health of Canadians. Funding supports glycomics translational research into post-surgical pain management, cancer diagnosis, and treatment of Parkinson’s disease, infectious diseases and chronic illness.
By Ali Chou In her lab in Edmonton, Alberta, Dr. Lori West, a GlycoNet Investigator, is overseeing the analysis of biological samples from pediatric heart …
Canadian researchers and Taiwanese institution break boundaries to advance glycomics research by Ali Chou GlycoNet Investigators giving lectures at Short Courses in Frontier Science and …
Network investigators and trainees will receive communications support to promote their research and its positive impact by GlycoNet Staff The Canadian Glycomics Network (GlycoNet) recently …
he Canadian research ecosystem works for the well-being of all Canadians. It is founded on multidisciplinary and translational innovation and fuelled by partnerships between a vibrant university research sector and industry.Politicians have long understood that a national alignment of research priorities helps find concrete solutions to the current and future needs of Canadians. Cross-country research collaboration also allows all provinces, including Alberta, to attract and retain talent and to diversify their economy.
By Marie-Christine Houle As Canadian Alzheimer’s Awareness Month wraps up, we shed some light on the work of Matthew Macauley, a GlycoNet investigator and professor …
Keeping the gut microbiota, the micro-organisms living in our intestines, in balance is important in preventing disease.A GlycoNet-funded project is looking at using glycans (sugars) to restore an imbalance that occurs in patients suffering from inflammatory bowel disease (IBD).
Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.